Prevention guidelines and EAS/ESC guidelines for the treatment of dyslipidaemias: A look to the future

Affiliations

¹ Department of Pharmacological and Biomolecular Sciences, University of Milan, Italy; IRCCS MultiMedica, Sesto S. Giovanni, Milan, Italy. Electronic address: alberico.catapano@unimi.it.
² Imperial Centre for Cardiovascular Disease Prevention, School of Public Health, Imperial College London, London, United Kingdom. Electronic address: k.ray@imperial.ac.uk.
³ Department of Cardiology, Hacettepe University Faculty of Medicine, Ankara, Turkey. Electronic address: laletok@gmail.com.

Comment

Alberico L Catapano et al. Atherosclerosis. 2022 Jan.

. 2022 Jan:340:51-52.

doi: 10.1016/j.atherosclerosis.2021.11.021. Epub 2021 Nov 26.

¹ Department of Pharmacological and Biomolecular Sciences, University of Milan, Italy; IRCCS MultiMedica, Sesto S. Giovanni, Milan, Italy. Electronic address: alberico.catapano@unimi.it.
² Imperial Centre for Cardiovascular Disease Prevention, School of Public Health, Imperial College London, London, United Kingdom. Electronic address: k.ray@imperial.ac.uk.
³ Department of Cardiology, Hacettepe University Faculty of Medicine, Ankara, Turkey. Electronic address: laletok@gmail.com.

No abstract available

Keywords: Cardiovascular disease; Dyslipidemia; EAS; ESC; Guidelines.

Comment on

2021 ESC Guidelines on cardiovascular disease prevention in clinical practice.
Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, Bäck M, Benetos A, Biffi A, Boavida JM, Capodanno D, Cosyns B, Crawford C, Davos CH, Desormais I, Di Angelantonio E, Franco OH, Halvorsen S, Hobbs FDR, Hollander M, Jankowska EA, Michal M, Sacco S, Sattar N, Tokgozoglu L, Tonstad S, Tsioufis KP, van Dis I, van Gelder IC, Wanner C, Williams B; ESC National Cardiac Societies; ESC Scientific Document Group. Visseren FLJ, et al. Eur Heart J. 2021 Sep 7;42(34):3227-3337. doi: 10.1093/eurheartj/ehab484. Eur Heart J. 2021. PMID: 34458905 No abstract available.